Literature DB >> 23480228

Progesterone treatment decreases traumatic brain injury induced anxiety and is correlated with increased serum IGF-1 levels; prefrontal cortex, amygdala, hippocampus neuron density; and reduced serum corticosterone levels in immature rats.

B Baykara1, I Aksu, E Buyuk, M Kiray, A R Sisman, B Baykara1, A Dayi, A Tas, D Ozdemir, M N Arda, N Uysal.   

Abstract

Traumatic brain injury (TBI) may cause neuropsychiatric problems, such as anxiety disorder, that have negative effects on cognitive functions and behavior. We investigated the effects of progesterone on traumatic brain injury induced anxiety in 7-day-old rat pups subjected to contusion injury. Progesterone treatment decreased TBI induced anxiety and serum corticosterone levels, and increased serum IGF-1 levels. Moreover, progesterone treatment increased amygdala, prefrontal cortex and hippocampal neuron density. We found a negative correlation between serum corticosterone levels and anxiety tests, and a positive correlation between serum IGF-1 levels and anxiety tests. In addition, progesterone treatment decreased serum corticosterone compared to the controls and sham. Our results indicate that single dose progesterone may be effective for treating anxiety caused by TBI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23480228     DOI: 10.3109/10520295.2013.769630

Source DB:  PubMed          Journal:  Biotech Histochem        ISSN: 1052-0295            Impact factor:   1.718


  17 in total

1.  Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer's Disease.

Authors:  Shuhua Chen; Tian Wang; Jia Yao; Roberta Diaz Brinton
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 2.  Progesterone for neuroprotection in pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Emin Fidan; Rachel M Stanley; Corina Noje; Hülya Bayir
Journal:  Pediatr Crit Care Med       Date:  2015-03       Impact factor: 3.624

3.  Progesterone protects mitochondrial function in a rat model of pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Manda Saraswati
Journal:  J Bioenerg Biomembr       Date:  2014-10-28       Impact factor: 2.945

4.  Progesterone increased β-endorphin innervation of the locus coeruleus, but ovarian steroids had no effect on noradrenergic neurodegeneration.

Authors:  Fernanda B Lima; Cristiane M Leite; Cynthia L Bethea; Janete A Anselmo-Franci
Journal:  Brain Res       Date:  2017-03-08       Impact factor: 3.252

5.  Anticonvulsant Effect of Asparagus racemosus Willd. in a Mouse Model of Catamenial Epilepsy.

Authors:  Priyanka Pahwa; Tanveer Singh; Rajesh Kumar Goel
Journal:  Neurochem Res       Date:  2021-10-08       Impact factor: 3.996

6.  Ferulic acid inhibits catamenial epilepsy through modulation of female hormones.

Authors:  Harleen Kaur Dhillon; Tanveer Singh; Rajesh Kumar Goel
Journal:  Metab Brain Dis       Date:  2022-08-06       Impact factor: 3.655

Review 7.  Brain Trauma, Glucocorticoids and Neuroinflammation: Dangerous Liaisons for the Hippocampus.

Authors:  Ilia G Komoltsev; Natalia V Gulyaeva
Journal:  Biomedicines       Date:  2022-05-15

Review 8.  Sex-related responses after traumatic brain injury: Considerations for preclinical modeling.

Authors:  Claudia B Späni; David J Braun; Linda J Van Eldik
Journal:  Front Neuroendocrinol       Date:  2018-05-18       Impact factor: 8.606

9.  Progesterone treatment following traumatic brain injury in the 11-day-old rat attenuates cognitive deficits and neuronal hyperexcitability in adolescence.

Authors:  Dana Lengel; Jimmy W Huh; Jessica R Barson; Ramesh Raghupathi
Journal:  Exp Neurol       Date:  2020-04-23       Impact factor: 5.330

10.  Therapeutic effects of progesterone and its metabolites in traumatic brain injury may involve non-classical signaling mechanisms.

Authors:  Paul S Cooke; Manjunatha K Nanjappa; Zhihui Yang; Kevin K W Wang
Journal:  Front Neurosci       Date:  2013-06-13       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.